The global epidemiology of hepatocellular carcinoma: present and future
- PMID: 21689610
- PMCID: PMC4141529
- DOI: 10.1016/j.cld.2011.03.006
The global epidemiology of hepatocellular carcinoma: present and future
Abstract
The global risk of hepatocellular carcinoma (HCC) has been largely driven by hepatitis B virus (HBV) infection for the past century, along with hepatitis C virus (HCV), aflatoxin, excessive alcohol consumption, and obesity/diabetes. The dominant effect of HBV on global HCC risk should decline as the population vaccinated against HBV grows older. Infection with HCV is also expected to decline. Projections of HCV-related HCC rates remaining high for another 30 years may be overly pessimistic. Alcohol may be less of a factor in HCC in coming years. However, obesity and diabetes may become even more important risk factors for HCC.
Copyright © 2011. Published by Elsevier Inc.
Figures
References
-
- Ferlay J, Shin H, Bray F, D F, C M, Parkin DM GLOBOCAN. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] 2008 http://globocan.iarc.fr.
-
- Zimmerman M, Aufderheide AC. Paleopath Newsletter. 2010;150:16–23.
-
- Frerichs FT. A clinical treatise on diseases of the liver. New York: Wood; 1879.
-
- Osler W, McCrae T. The principles and practice of medicine: designed for the use of practitioners and students of medicine. Eighth ed. New York: D. Appleton and Company; 1912.
-
- Ferlay J, Parkin DM, Curado MP, et al. Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9 [Internet] http://ci5.iarc.fr.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
